Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Breast Cancer Research and Treatment|February 28, 2026
Real-world second- and third-line progression-free survival after progression on first-line CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer by PAM50 intrinsic subtype: the SOLTI-1801 CDK-PREDICT studyPablo Tolosa, Isabel García-Fructuoso, Tomás Pascual, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2025
Associations of the HER2DX Genomic Test with Biological and Pathological Features in HER2-positive Breast CancerEsther Sanfeliu, Anabel Martínez-Romero, Mercedes Marín-Aguilera, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 25, 2018
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registryAlberto Carmona-Bayonas, Paula Jiménez-Fonseca, Isabel Echavarria, et al.
British Journal of Cancer|August 3, 2017
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer RegistryPaula Jiménez Fonseca, Alberto Carmona-Bayonas, Raquel Hernández, et al.
Nature Communications|March 1, 2023
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancerAleix Prat, Fara Brasó-Maristany, Olga Martínez-Sáez, et al.
Thrombosis and Haemostasis|August 29, 2019
Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with CancerAlberto Carmona-Bayonas, Paula Jimenez-Fonseca, Marcelo Garrido, et al.
NPJ Breast Cancer|April 25, 2025
HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumabRodrigo Sánchez-Bayona, Olga Martínez-Sáez, Denys Romero-Romero, et al.
Frontiers in Oncology|May 15, 2023
HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancerRubén Olivera-Salguero, Elia Seguí, Juan Miguel Cejalvo, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 8, 2016
Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancerPaula Jiménez-Fonseca, Alberto Carmona-Bayonas, Maria Luisa Sánchez Lorenzo, et al.
Nature Communications|July 11, 2024
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early responseFara Brasó-Maristany, Juan Manuel Ferrero-Cafiero, Claudette Falato, et al.
Pageof 11